• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hepatol Int . Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China

tetano

Editor, Senior Moderator
Hepatol Int


. 2020 Oct 7.
doi: 10.1007/s12072-020-10075-5. Online ahead of print.
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China


Ming Wang[SUP] 1 [/SUP], Weiming Yan[SUP] 1 [/SUP], Weipeng Qi[SUP] 1 [/SUP], Di Wu[SUP] 1 [/SUP], Lin Zhu[SUP] 1 [/SUP], Weina Li[SUP] 1 [/SUP], Xiaojing Wang[SUP] 1 [/SUP], Ke Ma[SUP] 1 [/SUP], Ming Ni[SUP] 1 [/SUP], Dong Xu[SUP] 1 [/SUP], Hongwu Wang[SUP] 1 [/SUP], Guang Chen[SUP] 1 [/SUP], Haijing Yu[SUP] 1 [/SUP], Hongfang Ding[SUP] 1 [/SUP], Mingyou Xing[SUP] 1 [/SUP], Meifang Han[SUP] 1 [/SUP], Xiaoping Luo[SUP] 2 [/SUP], Tao Chen[SUP] 1 [/SUP], Wei Guo[SUP] 3 [/SUP], Dong Xi[SUP] 4 [/SUP], Qin Ning[SUP] 5 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) has rapidly become a major international public health concern. This study was designed to evaluate the clinical characteristics and risk factors of COVID-19-associated liver injury.
Methods: A fraction of 657 COVID-19 patients were retrospectively analyzed. Clinical and laboratory data were derived from electronic medical records and compared between patients with or without liver injury. Multivariate logistic regression method was used to analyze the risk factors for liver injury.
Results: Among 657 patients, 303 (46.1%) patients had liver injury with higher rate in severe/critically ill patients [148/257 (57.6%)] than those in moderate cases [155/400 (38.8%)]. The incidence of liver injury was much higher in male [192/303 (63.4%)] than female [111/303 (36.6%)], and in severe/critical patients [148/303 (48.8%)] with percutaneous oxygen saturation ≤ 93% [89/279 (31.9%)] or peak body temperature ≥ 38.5 ?C [185/301 (61.5%)] on admission. Liver injury-related inflammations included increased white blood cells, neutrophils and decreased lymphocytes. More patients with liver injury than without had increased serum IL-2R, TNFα, ferritin, hsCRP, PCT, ESR, γ-GT, and LDH. Multivariate regression analysis revealed that increasing odds of liver injury were related to male, higher serum hsCRP (≥ 10 mg/L), and neutrophil-to-lymphocyte ratio (NLR) (≥ 5). Moreover, more deceased patients (14/82 (17%)) had significantly elevated serum TBIL than discharged patients [25/532 (4.7%)].
Conclusion: Liver injury is a common complication in COVID-19 patients. The potential risk factors of liver injury include male, hsCRP and NLR score. A close monitor of liver function should be warned in COVID-19 patients, especially in severe/critical individuals.

Keywords: Alanine aminotransferase; COVID-19; Clinical course; Cytokine storm; Hypersensitive C-reactive protein; Liver damage; Multivariate regression analysis; Neutrophil-to-lymphocyte ratio; Retrospective cohort study; Total bilirubin.
 
Back
Top Bottom